title: Diagnosis of pancreatic tumors by endoscopic ultrasound-guided fine-needle aspiration.
abstract: OBJECTIVE
  To evaluate the diagnostic accuracy of endoscopic ultrasound-guided fine-needle aspiration (EUS-FNA) for pancreatic solid tumors larger or smaller than 3 cm, and cystic lesions.
  
  
  METHODS
  From January/1997 to December/2006, 611 patients with pancreatic tumors were subjected to EUS-FNA. The final diagnosis was obtained either by surgery (356 cases) or after a mean clinical follow-up of 11.8 mo in the remaining patients.
  
  
  RESULTS
  There were 405 solid tumors, 189 cystic lesions and 17 mixed. Pancreatic specimens for cytological assessment were successfully obtained by EUS-FNA in 595 (97.4%) cases. There were 352 (57.6%) malignancies and 259 (42.4%) benign tumors. Among the malignancies, pancreatic adenocarcinomas accounted for 67% of the lesions. Overall, the sensitivity, specificity, positive and negative predictive values, and accuracy of EUS-FNA were, respectively, 78.4%, 99.2%, 99.3%, 77.2% and 87.2%. Specifically for solid tumors, the same parameters for neoplasms larger and smaller than 3 cm were, respectively, 78.8% vs 82.4%, 100% vs 98.4%, 100% vs 99%, 54.8% vs 74.1% and 83.1% vs 87.8%. For cystic lesions, the values were, respectively, 72.2%, 99.3%, 97.5%, 91% and 92.2%.
  
  
  CONCLUSIONS
  EUS-FNA can be used to sample pancreatic tumors in most patients. Even though the negative predictive value is inadequate for large solid tumors, the results are rather good for small solid tumors, especially concerning the sensitivity, negative predictive value and diagnostic accuracy. Among all pancreatic lesions, EUS-FNA for cystic lesions can reveal the best negative predictive value and diagnostic accuracy, both higher than 90%.
authors.affiliation: Echoendoscopy and Pathology Units from 9 de Julho Hospital and Ribeirao Preto Medical School-USP, Cristiano Fischer 668/1001, C.E.P. 91.410-000 Porto Alegre-RS, Brazil.
authors.forename: Jose-Celso
authors.initials: JC
authors.lastname: Ardengh
authors.forename: Cesar-Vivian
authors.initials: CV
authors.lastname: Lopes
authors.forename: Luiz-Felipe Pereira
authors.initials: LF
authors.lastname: de Lima
authors.forename: Juliano-Rodrigues
authors.initials: JR
authors.lastname: de Oliveira
authors.forename: Filadelfio
authors.initials: F
authors.lastname: Venco
authors.forename: Giulio-Cesare
authors.initials: GC
authors.lastname: Santo
authors.forename: Jose-Luiz-Pimenta
authors.initials: JL
authors.lastname: Modena
mesh_terms: D000230:Adenocarcinoma / Q000000981:diagnostic imaging* / Q000473:pathology; D000293:Adolescent; D000328:Adult; D000368:Aged; D000369:Aged, 80 and over; D044963:Biopsy, Fine-Needle / Q000379:methods*; D002648:Child; D019160:Endosonography / Q000379:methods*; D005260:Female; D006801:Humans; D008297:Male; D008875:Middle Aged; D010190:Pancreatic Neoplasms / Q000000981:diagnostic imaging* / Q000473:pathology; D011237:Predictive Value of Tests; D012189:Retrospective Studies; D012680:Sensitivity and Specificity